Suchergebnisse - "Fibrinolytic Agents"

PubPharm (63)

1

Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes

enthalten in: American heart journal | 2017

von Ducrocq, G. | Schulte, P. | Budaj, A. | +13

2

Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients : Insights from the STrategic Reperfusion Early After Myocardial infarction trial

enthalten in: American heart journal | 2015

von Armstrong, P. | Zheng, Y. | Westerhout, C. | +8

ErratumIn: Am Heart J. 2017 Feb;184:157. - PMID 28224932

3

Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury : rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial

enthalten in: American heart journal | 2012

von Steering Committee | Konstantinides, S. | Meyer, G. | +26

4

The association between early ventricular arrhythmias, renin-angiotensin-aldosterone system antagonism, and mortality in patients with ST-segment-elevation myocardial infarction : Insights from Global Use of Strategies to Open coronary arteries (GUSTO) V

enthalten in: American heart journal | 2009

von Askari, A. | Shishehbor, M. | Kaminski, M. | +4

5

Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis--the CaVenT study : rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771)

enthalten in: American heart journal | 2007

von Enden, T. | Sandvik, L. | Kløw, N. | +8

6

Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction : results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial

enthalten in: American heart journal | 2007

von Greenbaum, A. | Ohman, E. | Gibson, C. | +7

CommentIn: Am Heart J. 2007 Oct;154(4):603-6. - PMID 17892976

7

Does coronary angioplasty after timely thrombolysis improve microvascular perfusion and left ventricular function after acute myocardial infarction?

enthalten in: American heart journal | 2007

von Agati, L. | Funaro, S. | Madonna, M. | +3

8

Recombinant P-selectin glycoprotein ligand-immunoglobulin, a P-selectin antagonist, as an adjunct to thrombolysis in acute myocardial infarction. The P-Selectin Antagonist Limiting Myonecrosis (PSALM) trial

enthalten in: American heart journal | 2006

von Mertens, P. | Maes, A. | Nuyts, J. | +10

9

Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction : results from the prematurely terminated ADdressing the Value of facilitated ANgioplasty after Combination therapy or Eptifibatide monotherapy in acute Myocardial Infarction (ADVANCE MI) trial

enthalten in: American heart journal | 2005

von ADVANCE MI Investigators

ErratumIn: Am Heart J. 2005 Sep;150(3):391

10

Incidence, predictors, and outcomes of high-degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapy

enthalten in: American heart journal | 2005

von Meine, T. | Al-Khatib, S. | Alexander, J. | +7

1
2
3
4
5
6
7
Nächster »
[7]